Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis
British Journal of Biomedical Science · 16.06.2023 · 80
DOI: 10.3389/bjbs.2023.11065 ↗Kurz gefasst
Metaanalyse in der Zeitschrift British Journal of Biomedical Science, online erschienen am 16.06.2023. Verfasst von Mohammed Haseeb Chohan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Faculty of Health, University of Plymouth, Plymouth, United Kingdom. Hauptthemen laut MEDLINE: Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Plymouth University.
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma (OSCC) is a common malignant cancer in humans. An abundance of tumour associated macrophages (TAMs) create an immunosuppressive tumour microenvironment (TME). TAM markers (CD163 and CD68) are seen to serve as prognostic factors in OSCC. PD-L1 has seen to widely modulate the TME but its prognostic significance remains controversial. The aim of this meta-analysis is to evaluate the prognostic role of CD163 + , CD68 + TAMs and PD-L1 in OSCC patients.
Methods
Searches in PubMed, Scopus and Web of Science were performed; 12 studies were included in this meta-analysis. Quality assessment of included studies was performed according to REMARK guidelines. Risk of bias across studies was investigated according to the rate of heterogeneity. Meta-analysis was performed to investigate the association of all three biomarkers with overall survival (OS).
Results
High expression of CD163 + TAMs were associated with poor overall survival (HR = 2.64; 95% Cl: [1.65, 4.23]; p < 0.0001). Additionally, high stromal expression of CD163 + TAMs correlated with poor overall survival (HR = 3.56; 95% Cl: [2.33, 5.44]; p < 0.00001). Conversely, high CD68 and PD-L1 expression was not associated with overall survival (HR = 1.26; 95% Cl: [0.76, 2.07]; p = 0.37) (HR = 0.64; 95% Cl: [0.35, 1.18]; p = 0.15).
Conclusion
In conclusion, our findings indicate CD163 + can provide prognostic utility in OSCC. However, our data suggests CD68 + TAMs were not associated with any prognostic relevance in OSCC patients, whereas PD-L1 expression may prove to be a differential prognostic marker dependent on tumour location and stage of progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
- School of Dentistry, Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
Förderung
- Plymouth University
Zitieren
APA
Chohan, M. H., Perry, M., Laurance-Young, P., Salih, V. M., & Foey, A. D. (2023). Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis. British Journal of Biomedical Science, 80. https://doi.org/10.3389/bjbs.2023.11065
Vancouver
Chohan MH, Perry M, Laurance-Young P, Salih VM, Foey AD. Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis. British Journal of Biomedical Science. 2023;80. doi:10.3389/bjbs.2023.11065
BibTeX
@article{Chohan2023,
author = {Chohan, Mohammed Haseeb and Perry, Matthew and Laurance-Young, Paul and Salih, Vehid M and Foey, Andrew D},
title = {Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis},
journal = {British Journal of Biomedical Science},
year = {2023},
volume = {80},
doi = {10.3389/bjbs.2023.11065}
}
EUVIMED